NEW YORK : The experimental antibody cocktail which US President Donald Trump received when he tested positive for COVID-19 offers benefits against the novel coronavirus infection, according to a new study in animal models which provides more evidence of the clinical potential of the therapeutic.While earlier studies had shown that the cocktail of two antibodies targeting the coronavirus spike protein could be used to neutralise the pathogen, scientists from the American biotechnology company Regeneron noted that further research in multiple animal models is needed to test the effectiveness of the formulation.In the current study, published in the journal Science, the researchers tested REGN-COV2 in rhesus macaques, which manifest mild.